GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 111 filers reported holding GOSSAMER BIO INC in Q1 2023. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,014,162 | +118.8% | 2,771,503 | +1107.9% | 0.05% | +72.4% |
| Q3 2022 | $2,749,000 | +125.3% | 229,445 | +57.4% | 0.03% | +163.6% |
| Q2 2022 | $1,220,000 | -26.2% | 145,746 | -23.5% | 0.01% | +10.0% |
| Q1 2022 | $1,653,000 | -20.5% | 190,473 | +3.6% | 0.01% | -9.1% |
| Q4 2021 | $2,079,000 | +112.8% | 183,844 | +136.4% | 0.01% | +57.1% |
| Q3 2021 | $977,000 | +6.7% | 77,760 | -31.1% | 0.01% | +16.7% |
| Q2 2021 | $916,000 | -43.0% | 112,850 | -35.0% | 0.01% | -45.5% |
| Q1 2021 | $1,606,000 | +563.6% | 173,628 | +594.1% | 0.01% | +450.0% |
| Q4 2020 | $242,000 | -59.3% | 25,016 | -47.7% | 0.00% | -71.4% |
| Q3 2020 | $594,000 | +172.5% | 47,833 | +184.9% | 0.01% | +133.3% |
| Q2 2020 | $218,000 | -67.4% | 16,791 | -60.7% | 0.00% | -70.0% |
| Q4 2019 | $668,000 | – | 42,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |